A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase. [PDF]
, 1986 Hideki Fujiwara +6 more
openalex +1 more source
Local thrombolysis in the treatment of arterial graft occlusions [PDF]
, 1984 Arina van Breda +6 more
openalex +1 more source
Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up? [PDF]
, 2020 Alteplase is the only Food and Drug Administration-approved intravenous (IV) thrombolytic medication for acute ischemic stroke. However, multiple recent studies comparing tenecteplase and alteplase suggest that tenecteplase is at least as efficacious as ...
Ataya, Ramsey, Brea, Isabel, Zitek, Tony
core
Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits [PDF]
, 1985 Giancarlo Agnelli +4 more
openalex +1 more source
Intracranial thrombolysis via a catheter embedded in the clot. [PDF]
, 1989 Charles A. Jungreis +2 more
openalex +1 more source
Door to Needle Time and its Impact on Successful Thrombolysis
Journal of Rawalpindi Medical College, 2012 Background: To evaluate the Door to needle time and its impact on successful thrombolysis . Methods : In this cross sectional study all patients admitted with Acute Myocardial Infarction (AMI), who were candidates for fibrinolysis, were included ...
Sarfaraz Ali Zahid
doaj
Portal vein thrombosis after laparoscopic splenectomy: an ongoing clinical challenge. [PDF]
, 2005 ObjectivesPortal vein thrombosis (PVT) following open splenectomy is a potentially lethal complication with an incidence of up to 6%. The objective of this report is to describe our management of a recent laparoscopic case, discuss current therapies, and
Kee, Stephen T +4 more
core +2 more sources
Ultrasound-Enhanced Thrombolysis
Journal of Endovascular Therapy, 2007 Purpose: To report a single-center clinical experience with ultrasound-enhanced thrombolysis in the treatment of both arterial and venous thromboses. Methods: From January 2005 to June 2006, 33 patients (23 men; age range 39–90 years) with 36 occlusions were treated using ultrasound-enhanced thrombolytic therapy for acute and chronic arterial and ...
openaire +3 more sources
Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics. [PDF]
, 1989 Richard M. Prewitt +4 more
openalex +1 more source
Journal of the American College of Cardiology, 1990 Robert M. Califf +1 more
openaire +3 more sources